Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000134

Director acquired 5,967 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Erik Director 2024-05-31 Grant or award +5,967 17,052 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Erik Director 2024-05-31 Grant or award · Stock Option (right to buy) +17,901 17,901 D: show line 2 in the form
Loading xslF345X05/wk-form4_1717540070.xml…